Table 9.
LD 1 | LD 2 | LD 3 | LD 4 | LD 5 | LD 6 | LD 7 | LD 8 | n | ||
---|---|---|---|---|---|---|---|---|---|---|
IGF-1 | β | −0.014 | −0.017 | 0.001 | −0.029 | −0.028 | 0.020 | 0.038 | 0.004 | |
s.e. | 0.023 | 0.013 | 0.017 | 0.014 | 0.015 | 0.029 | 0.026 | 0.016 | 958 | |
p | 0.562 | 0.208 | 0.955 | 0.034 | 0.057 | 0.491 | 0.144 | 0.783 | ||
Chemerin | β | −0.001 | −0.014 | −0.017 | −0.014 | −0.015 | 0.010 | −0.017 | −0.021 | |
s.e. | 0.024 | 0.014 | 0.017 | 0.014 | 0.015 | 0.030 | 0.027 | 0.017 | 929 | |
p | 0.961 | 0.306 | 0.312 | 0.337 | 0.332 | 0.748 | 0.528 | 0.203 | ||
Progranulin | β | 0.027 | 0.007 | 0.013 | 0.008 | 0.007 | 0.019 | 0.005 | 0.006 | |
s.e. | 0.019 | 0.011 | 0.014 | 0.011 | 0.012 | 0.023 | 0.021 | 0.013 | 957 | |
p | 0.156 | 0.513 | 0.336 | 0.472 | 0.541 | 0.424 | 0.801 | 0.668 | ||
AFABP | β | 0.088 | 0.027 | 0.026 | 0.019 | 0.013 | 0.020 | 0.010 | 0.029 | |
s.e. | 0.040 | 0.023 | 0.029 | 0.024 | 0.025 | 0.050 | 0.045 | 0.028 | 930 | |
p | 0.028 | 0.245 | 0.364 | 0.416 | 0.612 | 0.690 | 0.827 | 0.296 | ||
Adiponectin | β | 0.057 | −0.011 | 0.014 | −0.014 | −0.008 | 0.014 | 0.008 | −0.004 | |
s.e. | 0.026 | 0.015 | 0.019 | 0.015 | 0.016 | 0.032 | 0.029 | 0.018 | 928 | |
p | 0.031 | 0.482 | 0.458 | 0.343 | 0.637 | 0.660 | 0.786 | 0.807 | ||
Irisin | β | −0.001 | −0.002 | −0.017 | 0.002 | −0.008 | 0.002 | −0.023 | −0.004 | |
s.e. | 0.025 | 0.014 | 0.018 | 0.015 | 0.016 | 0.031 | 0.027 | 0.017 | 954 | |
p | 0.984 | 0.878 | 0.336 | 0.869 | 0.624 | 0.939 | 0.401 | 0.810 | ||
Vaspin | β | 0.046 | −0.030 | 0.031 | −0.044 | −0.030 | 0.129 | 0.036 | 0.029 | |
s.e. | 0.078 | 0.045 | 0.055 | 0.046 | 0.049 | 0.095 | 0.085 | 0.054 | 952 | |
p | 0.562 | 0.500 | 0.577 | 0.333 | 0.536 | 0.173 | 0.674 | 0.586 | ||
AGF | β | 0.053 | 0.065 | −0,058 | 0.066 | 0.021 | 0.154 | 0.055 | −0.008 | |
s.e. | 0.101 | 0.057 | 0.072 | 0.059 | 0.063 | 0.125 | 0.110 | 0.069 | 768 | |
p | 0.600 | 0.256 | 0.999 | 0.263 | 0.737 | 0.218 | 0.616 | 0.904 | ||
pro-NT | β | −0.030 | −0.005 | −0.044 | −0.003 | −0.011 | −0.030 | −0.023 | −0.016 | |
s.e. | 0.031 | 0.018 | 0.022 | 0.018 | 0.019 | 0.037 | 0.034 | 0.021 | 953 | |
p | 0.323 | 0.758 | 0.045 | 0.869 | 0.562 | 0.438 | 0.495 | 0.449 | ||
PENK | β | 0.015 | 0.001 | 0.003 | −0.006 | 0.004 | 0.066 | 0.029 | 0.014 | |
s.e. | 0.021 | 0.012 | 0.015 | 0.012 | 0.013 | 0.025 | 0.023 | 0.014 | 953 | |
p | 0.480 | 0.958 | 0.827 | 0.604 | 0.770 | 0.009 | 0.195 | 0.336 |
The presented associations are given for the representative SNP within each LD-group. Prior to analysis, all variables were ln-transformed except the covariate sex. p-values were adjusted for: sex, age, BMI and a p-value 0.05 was considered to be significant and highlighted in bold. Linear regression including all subjects was conducted. LD = linkage disequilibrium; IGF-1 = insulin like growth factor 1; AFABP = adipocyte fatty acid-binding protein; AGF = angiopoietin-related growth factor; pro-NT = pro-neurotensin; PENK = pro-enkephalin; BMI = body-mass index; p = p-value; β = regression coefficient; s.e. = standard error; n = number of subjects.